Literature DB >> 7515758

Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease.

P Eikelenboom1, S S Zhan, W Kamphorst, P van der Valk, J M Rozemuller.   

Abstract

Integrins belonging to different subfamilies can be identified immunohistochemically in cerebral amyloid plaques. Monoclonal antibodies against the VLA family beta 1-integrins show staining of the corona of classical amyloid plaques for beta 1, alpha 3 and alpha 6. Immunostaining reveal also the presence of collagen and laminin in the corona. Activated microglial cells in classical plaques strongly express receptors belonging to the LeuCAM family (beta 2 integrins). The ligands ICAM and activated complement C3 are found in both amorphous and classical plaques. Vitronectin receptor (alpha v) is found in glial cells in classical plaques but its ligand vitronectin is seen in both amorphous and classical plaques. The data presented here demonstrate the presence of different cellular and substrate adhesive molecules (integrins) and their ligands in classical plaques. The findings suggest that amyloid plaques show signs of regeneration and tissue remodelling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515758     DOI: 10.1007/bf00190565

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  63 in total

Review 1.  Extracellular matrix molecules that influence neural development.

Authors:  J R Sanes
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

Review 2.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 3.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process.

Authors:  P Eikelenboom; J M Rozemuller; G Kraal; F C Stam; P A McBride; M E Bruce; H Fraser
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1991

5.  Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

Authors:  P Eikelenboom; F C Stam
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

6.  Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue.

Authors:  H Akiyama; T Kawamata; S Dedhar; P L McGeer
Journal:  J Neuroimmunol       Date:  1991-04       Impact factor: 3.478

7.  Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques.

Authors:  T Ishii; S Haga
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 8.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95.

Authors:  G D Keizer; J Borst; C G Figdor; H Spits; F Miedema; C Terhorst; J E De Vries
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

10.  The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.

Authors:  E Pearlstein; J Sorvillo; I Gigli
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

View more
  15 in total

1.  Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.

Authors:  S Webster; B Bonnell; J Rogers
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors:  F L Van Muiswinkel; P Eikelenboom
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 3.  The significance of neuroinflammation in understanding Alzheimer's disease.

Authors:  P Eikelenboom; R Veerhuis; W Scheper; A J M Rozemuller; W A van Gool; J J M Hoozemans
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

4.  Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells.

Authors:  T Yamazaki; E H Koo; D J Selkoe
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

5.  Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Authors:  Douglas G Walker; Lih-Fen Lue; Tiffany M Tang; Charles H Adler; John N Caviness; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

6.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 7.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Regulation of the hyperpolarization-activated cationic current Ih in mouse hippocampal pyramidal neurones by vitronectin, a component of extracellular matrix.

Authors:  Dmitry V Vasilyev; Michael E Barish
Journal:  J Physiol       Date:  2004-08-19       Impact factor: 5.182

Review 10.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.